Access cutting-edge brain metastases treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access brain metastases specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain metastases treatment provided free
This research study is studying This research study is studying the efficacy and safety of the following study drugs as a possible treatment for recurrent central nervous system (CNS) metastases: * Palbociclib alone (Cohort 1) * The combination of palbociclib and pembrolizumab (Cohort 2) Pfizer and Merck, pharmaceutical companies, are supporting this research study by providing the study drugs as well as funding for research activities.
Sponsor: Massachusetts General Hospital
Check if you qualify for this brain metastases clinical trial in Boston, MA
If you're searching for brain metastases treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain metastases specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.